FIVE STAR PRODUCTS INC
10-Q, 1999-11-15
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: ALL STAR GAS CORP, NT 10-Q, 1999-11-15
Next: DICKSTEIN PARTNERS INC, 13F-HR, 1999-11-15



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 10-Q



[X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities  Exchange
Act of 1934 For the quarter ended September 30, 1999

                                       or

[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
For the transition period from                       to
Commission File Number:                             033-78252

                            FIVE STAR PRODUCTS, INC.

             (Exact Name of Registrant as Specified in its Charter)

Delaware                                                     13-3729186
(State or other jurisdiction of                           (I.R.S. Employer
incorporation or organization)                             Identification No.)

9 West 57th Street, New York, NY                                10019
(Address of principal executive offices)                      (Zip code)

(212) 230-9500
(Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange act of 1934 during
the  preceding 12 months (or for such shorter  period) that the  registrant  was
required  to file  such  reports  and  (2)  has  been  subject  to  such  filing
requirements for the past 90 days.


                           Yes    X                  No______


Number of shares  outstanding of each of issuer's  classes of common stock as of
November 12, 1999:

            Common Stock                                    13,020,155 shares

<PAGE>

                    FIVE STAR PRODUCTS, INC. AND SUBSIDIARIES

                                TABLE OF CONTENTS


                                                                    Page No.

Part I.    Financial Information


            Consolidated Condensed Balance Sheets -
              September 30, 1999 and December 31, 1998                    1

           Consolidated Condensed Statements of Operations-
              Three Months and Nine Months Ended September 30,
                1999 and 1998                                             3

           Consolidated Condensed Statements of Cash Flows -
              Nine Months Ended September 30, 1999 and 1998               4

            Notes to Consolidated Condensed Financial
                Statements                                                5

           Management's Discussion and Analysis of Financial
              Condition and Results of Operations                         7

           Qualification Relating to Financial Information               11

Part II.   Other Information                                             12

           Signatures                                                    13



<PAGE>



                          PART I. FINANCIAL INFORMATION

                    FIVE STAR PRODUCTS, INC. AND SUBSIDIARIES

                      CONSOLIDATED CONDENSED BALANCE SHEETS

                                 (in thousands)



                                                September 30,       December 31,
                                                  1999                    1998
     ASSETS                                     (unaudited)               *
Current assets

Cash                                            $        89        $      119
Accounts receivable, net                             12,065             9,697
Inventory (finished goods)                           20,907            22,446
Prepaid expenses and other current assets                55                29
                                                -----------       -----------

Total current assets                                 33,116            32,291
                                                   --------          --------

Property, plant and equipment, at cost                1,202               985
Less accumulated depreciation                          (306)             (173)
                                                 ----------         ---------
                                                        896               812
                                                -----------        ----------

Other assets                                             76                76
                                                -----------      ------------
                                                   $ 34,088          $ 33,179
                                                   ========          ========




* The  Consolidated  Condensed  Balance  Sheet as of December  31, 1998 has been
summarized  from the  Company's  audited  Consolidated  Balance Sheet as of that
date.


   See accompanying notes to the consolidated condensed financial statements.


<PAGE>


                    FIVE STAR PRODUCTS, INC. AND SUBSIDIARIES

                CONSOLIDATED CONDENSED BALANCE SHEETS (Continued)

                                 (in thousands)


                                                 September 30,     December 31,
                                                    1999                1998
                                                 (unaudited)              *

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities

Short-term borrowings                               $ 16,392         $ 16,971
Accounts payable and accrued expenses                 11,639           10,625
                                                     -------         --------
Total current liabilities                             28,031           27,596
                                                     -------        ---------

Long-term debt to GP Strategies                        5,000            5,000
                                                     -------        ---------

Stockholders' equity

Common stock                                             130              130
Capital in excess of par value                         7,589            7,589
Accumulated deficit                                   (6,662)          (7,136)
                                                   ---------        ---------

Total stockholders' equity                             1,057              583
                                                   ---------       ----------
                                                    $ 34,088         $ 33,179
                                                    ========         ========




* The  Consolidated  Condensed  Balance  Sheet as of December  31, 1998 has been
summarized from the Company's audited Consolidated Balance sheet as of that date


   See accompanying notes to the consolidated condensed financial statements.



<PAGE>


                    FIVE STAR PRODUCTS, INC. AND SUBSIDIARIES

                 CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS

                                   (Unaudited)

                      (in thousands, except per share data)

<TABLE>

<CAPTION>
                                                  Three months ended               Nine Months ended
                                                   September 30,                    September 30,

                                                 1999            1998              1999         1998
                                               --------        -------            ------      ------

<S>                                           <C>              <C>                            <C>
Sales                                         $ 21,241         $                $ 65,527      $  158
Cost of goods sold                              17,406                            54,411         142
                                              --------         -------          --------      ------
Gross margin                                     3,835                            11,116          16

Selling, general and administrative
 expenses                                       (3,036)          (155)            (8,917)       (585)
Consulting fee                                                      3                             83
Management fee to GP Strategies                    (30)           (30)               (90)        (90)

Interest expense                                  (457)                           (1,249)       (177)
                                              ---------        -------            -------     -------

Income (loss) before income taxes
 and extraordinary item                            312           (182)               860        (753)
Income tax expense                                (141)                             (386)
                                              ---------        -------           --------     -------
Income (loss) before extraordinary
 item                                              171           (182)               474         (753)

Extraordinary item
Early extinguishment of debt                                                                     (204)

Net income (loss)                            $     171        $  (182)           $   474      $  (957)
                                             =========        ========           =======       =======

Income (loss) per share
Basic before extraordinary item             $      .01        $  (.01)           $   .04      $  (.06)
Diluted before extraordinary item                  .01           (.01)               .03         (.06)
Basic net income (loss) per share                  .01           (.01)               .04         (.07)
Diluted net income (loss) per share                .01           (.01)               .03         (.07)
                                            ==========        ========           =======       ========
</TABLE>

   See accompanying notes to the consolidated condensed financial statements.


<PAGE>


                    FIVE STAR PRODUCTS, INC. AND SUBSIDIARIES

                 CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

                                   (Unaudited)
                                 (in thousands)
                                                            Nine months
                                                         ended September 30,
                                                         1999             1998
Cash flows from operations:
Net income (loss)                                     $   474           $ (957)
Adjustments to reconcile net loss
  to net cash used in operating activities:
 Depreciation and amortization                            133                5
 Loss from extinguishment of debt                                          204
 Deferred compensation                                                      40
 Changes in other operating items:
 Accounts receivable                                   (2,368)              (9)
 Inventory                                              1,539
 Prepaid expenses and other current assets                (26)
 Accounts payable and accrued expenses                  1,014
                                                    ---------           -------
 Net cash provided by (used in) operations                766             (717)
                                                    ---------           -------

Cash flows from investing activities:
Net assets of Five Star, less cash acquired                             (16,291)
Additions to property, plant and equipment               (217)
                                                    ---------           -------
Net cash used in investing activities                    (217)          (16,291)
                                                    ---------           -------

Cash flows from financing activities:
Net (repayments of) proceeds from
 short-term borrowings                                   (579)           16,476
Loans from GP Strategies                                                    545
                                                    ---------           -------
Net cash (used in) provided by financing
 activities                                              (579)           17,021
                                                    ---------           -------

Net (decrease) increase in cash                           (30)               13
Cash at beginning of period                               119               225
                                                    ---------         ---------
Cash at end of period                               $      89         $     238
                                                    =========         =========


   See accompanying notes to the consolidated condensed financial statements.



<PAGE>


                    FIVE STAR PRODUCTS, INC. AND SUBSIDIARIES

              NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                                   (Unaudited)

1.       Change of name

         On August 10, 1999 the  Stockholders of the Company voted to change its
name from American Drug Company to Five Star  Products,  Inc. The name change is
consistent  with the  transformation  of the Company into a distributor  of home
decorating, hardware and finishing products.

2.       Basis of reporting

         The accompanying  unaudited financial  statements have been prepared in
accordance with generally accepted  accounting  principles for interim financial
information  and with the  instructions to Form 10-Q.  Accordingly,  they do not
include all of the  information  and  footnotes  required by generally  accepted
accounting  principles  for  complete  financial  statements.  In the opinion of
management,  such statements include all adjustments  (consisting only of normal
recurring items) which are considered  necessary for a fair  presentation of the
Company's  financial  position at  September  30,  1999,  and the results of its
operations  and cash  flows for the nine  months  then  ended.  The  results  of
operations  for the  quarter and nine months  ended  September  30, 1999 are not
necessarily  indicative of the operating  results for the full year.  Results of
operations  and cash flows for the three and nine month periods ended  September
30, 1999 are not comparable to the  corresponding  periods of the prior year due
to the acquisition of the Five Star Group on September 30, 1998. It is suggested
that  these  financial  statements  be read in  conjunction  with the  financial
statements  and related  disclosures  included in the American Drug Company Form
10-K for the year ended December 31, 1998.


<PAGE>


                    FIVE STAR PRODUCTS, INC. AND SUBSIDIARIES

        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Continued)

                                   (Unaudited)

3.       Earnings (loss) per share

         Earnings  (loss) per share (EPS) for the quarter and nine months  ended
September  30,  1999 and 1998 are as  follows  (in  thousands,  except per share
amounts):

<TABLE>

<CAPTION>
                                                             Three months                     Nine months
                                                       ended September 30,                ended September 30,
                                                          1999           1998             1999           1998
Basic EPS
<S>                                                  <C>           <C>               <C>            <C>
         Net income (loss)                           $     171     $     (182)       $     474      $    (957)
         Weighted average shares
          Outstanding                                   13,020         13,020           13,020         13,020
         Basic earnings (loss) per share             $     .01     $     (.01)       $     .04      $    (.07)
                                                    ----------      --------         ---------      --------

Diluted EPS
         Net income (loss)                           $     171     $     (182)        $    474       $   (957)

         Weighted average shares
          outstanding                                   13,020         13,020           13,020         13,020
         Dilutive effect of stock options
          and warrants                                     825                             860
                                                    ----------     ------------        ---------   -------------
         Weighted average shares
          outstanding, diluted                          13,845         13,020           13,888         13,020
                                                      --------     ------------          -------   -------------

         Diluted earnings (loss) per share          $      .01     $    (.01)        $     .03      $   (.07)
                                                    ----------     ------------         ---------   ------------
</TABLE>

         Basic earnings per share are based upon the weighted  average number of
common  shares  outstanding  during the period.  Diluted  earnings per share are
based upon the weighted average number of common shares  outstanding  during the
period, assuming the issuance of common shares for all dilutive potential common
shares outstanding.


<PAGE>


                    FIVE STAR PRODUCTS, INC. AND SUBSIDIARIES

           MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

                            AND RESULTS OF OPERATIONS


Overview

On September  30, 1998, a newly formed  wholly-owned  subsidiary of the Company,
the Five Star Group, Inc. (Five Star) purchased from JL Distributors, Inc. (JL),
(formerly Five Star Group,  Inc.)  substantially all the operating assets of JL.
JL is a wholly-owned  subsidiary of GP Strategies  Corporation (GP  Strategies).
The assets were purchased for approximately $16,476,000 in cash and a $5,000,000
unsecured  five year senior  note.  Five Star is a leading  distributor  of home
decorating, hardware and finishing products in the northeast.

The  purchase by the Company of the assets of Five Star has changed the focus of
the Company. The Company plans to focus its efforts in the future on growing the
distribution  business,  and has taken several  steps to reduce its  traditional
operations from both a business and cost perspective.

As a result of the  purchase  of the assets of Five Star,  the  Company has shut
down its Moscow and  Washington  offices and scaled back the  operations  of its
Prague  office with respect to the business of NPD Trading.  For the nine months
ended September 30, 1999, the Company  incurred losses of $105,000 before income
taxes  related to the  business of NPD  Trading.  Of this  total,  approximately
$74,000 pertained to severance and shut down costs related to the Washington and
Prague offices.


Liquidity and Capital Resources

At  September  30,  1999  the  Company  had  cash of  $89,000.  Five  Star has a
$25,000,000  loan and  security  agreement  with a group of  banks.  The  credit
facility  allows Five Star to borrow up to 50% of eligible  inventory  and up to
80% of eligible accounts receivable.  At June 30, 1999, the Company had borrowed
$16,392,000  and had  $2,200,000  of  additional  availability  under  the  loan
agreement.

The  Company   believes  that  cash  generated  from  operations  and  borrowing
availability  under existing  credit  agreements  will be sufficient to fund the
working capital  requirements of Five Star as well as the limited  operations of
the Company's Prague office.

Results of Operations

Because of the  September  30, 1998  purchase of the assets of Five Star and the
change in focus of the Company,  results of operations  for the quarter and nine
months  ended  September  30,  1999  are  not  comparable  to  results  for  the
corresponding periods of the prior year.

<PAGE>

Sales

The Company had sales of $21,241,000  and  $65,527,000  for the quarter and nine
months  ended  September  30,  1999,  all of which were  generated by Five Star,
compared to sales of zero and  $158,000  for the  quarter and nine months  ended
September 30, 1998, which related to consulting revenue earned by the Company.

Gross margin

The Company had gross margin of $3,835,000 and  $11,116,000  for the quarter and
nine months ended  September  30, 1999,  compared to $16,000 for the nine months
ended September 30, 1998. The increased gross margin was the result of the sales
volume generated by Five Star during 1999. The Company  experienced an increased
gross margin percentage in the third quarter ended September 30, 1999,  compared
to the  first six  months  of the year due to  increased  sales  volume  and the
related operating  efficiencies  historically  experienced during the second and
third quarters of the year.

Selling, general and administrative expense

The Company had Selling, general and administrative (SG&A) expense of $3,036,000
and  $8,917,000  for the quarter  and nine  months  ended  September  30,  1999,
compared  to  $155,000  and  $585,000  for the  quarter  and nine  months  ended
September  30,1998.  The increased SG&A expense in 1999 is  attributable  to the
operations  of Five Star during  1999,  partially  offset by reduced  SG&A costs
incurred by the Company due to the shut down of the Moscow and  Washington  D.C.
offices, and the scaling back of operations in Prague.

Interest expense

The Company had interest  expense of $457,000 and $1,249,000 for the quarter and
nine months ended September 30, 1999,  compared to interest  expense of $177,000
for the nine months ended September  30,1998.  The increased interest expense in
1999 is the result of both the short-term  borrowings  incurred by Five Star, as
well as the interest  incurred on the $5,000,000  unsecured  senior note,  which
agreements were both entered into on September 30, 1998. The increased  interest
expense in 1999 was partially offset by the contribution to Capital in excess of
par value of the amount  owed by the Company to GP  Strategies  during the third
quarter of 1998.

Year 2000

The  Company  is aware of the issues  associated  with the  programming  code in
existing  computer systems as the millennium (year 2000)  approaches.  The "year
2000" problem is pervasive  and complex as virtually  every  computer  operation
will be affected in some way by the  rollover of the two digit year value to 00.
The issue is whether  computer  systems will properly  recognize  date sensitive
information  when  the  year  changes  to  2000.  Systems  that do not  properly
recognize such  information  could generate  erroneous data or cause a system to

<PAGE>

fail. The Company is utilizing both internal and external resources to identify,
correct or reprogram  and test systems for year 2000  compliance.  The Company's
primary operating  subsidiary,  Five Star during the second quarter of 1999 made
the  decision to modify their "home  grown"  systems to be year 2000  compliant.
Five Star has an implementation team led by the Director of Information Systems.
Five Star has completed the modifications  and has successfully  tested that the
software  is  year  2000  compliant.   In  addition,  Five  Star's  other  major
information system is its warehouse  management system.  Five Star has installed
and completed testing a current release that is year 2000 compliant.  There will
be no  additional  cost  to this  upgrade  since  all  upgrades  related  to the
warehouse system are included in yearly maintenance.

In  addition,  Five Star has examined  their  exposure to the year 2000 issue in
other areas of  technology.  These areas include  telephone and E-mail  systems,
operating systems and applications in free standing personal computers and other
areas of  communication.  A failure of these  systems  may impact the ability of
Five Star to service their customers which could have a material effect on their
results of operations. These issues have been handled by the information systems
and finance team at Five Star by  identifying  the problems and  obtaining  from
vendors and service providers either the necessary modifications to the software
or  assurances  that the systems will not be  disrupted.  In  addition,  certain
personal  computers and other equipment that is not year 2000 compliant has been
upgraded  through Five Star's normal  process of equipment  upgrades.  Five Star
believes that the evaluation and implementation process has been completed. Over
the next  year,  Five Star plans to  continue  to develop  and  implement  other
information technology projects needed in the ordinary course of business.

Five Star expects to finance these  expenditures  from a combination  of working
capital and  operating  leases for a portion of the new computer  equipment  and
software.  Five Star does not  expect  the year  2000  issue to have a  material
adverse impact on its financial position or results of operations.

Like other  companies,  the Company  relies on its customers for revenues and on
its vendors for products and services of all kinds; these third parties all face
the year 2000 issue.  An  interruption  in the ability of any of them to provide
goods or  services,  or to pay for goods or  services  provided  to them,  or an
interruption  in the business  operations of our customers  causing a decline in
demand for  services,  could have a material  adverse  effect on the  Company in
turn.

In addition,  there is a risk, the  probability of which the Company is not in a
position to estimate, that the transition to the year 2000 will cause wholesale,
perhaps    prolonged,    failures    of    electrical    generation,    banking,
telecommunications  or  transportation  systems in the United  States or abroad,
disrupting the general  infrastructure of business and the economy at large. The
effect of such disruptions on the Company could be material.

<PAGE>

The Company's  various  departments  are  continuing to  communicate  with their
principal  customers  and vendors about their year 2000  readiness.  None of the
responses  received to date  suggests  that any  significant  customer or vendor
expects the year 2000 issue to cause an  interruption  in its  operations  which
would have a material  adverse impact on the Company.  However,  because so many
firms are exposed to the risk of failure not only of their own  systems,  but of
the  systems  of other  firms,  the  ultimate  effect of the year 2000  issue is
subject to a very high degree of uncertainty.

The Company believes that its  preparations  currently under way are adequate to
assess and manage the risks presented by the year 2000 issue,  and does not have
a formal contingency plan at this time.

The  statements in this section  regarding the effect of the year 2000 issue and
the Company's responses to it are forward-looking  statements. They are based on
assumptions  that the Company  believes to be reasonable in light of its current
knowledge and experience.  A number of contingencies  could cause actual results
to differ materially from those described in forward-looking  statements made by
or on behalf of the Company.

Forward-Looking Statements

This report contains certain forward-looking  statements reflecting management's
current  views with respect to future events and  financial  performance.  These
forward-looking  statements are subject to certain risks and uncertainties  that
could   cause   actual   results  to  differ   materially   from  those  in  the
forward-looking  statements,  all of which are  difficult to predict and many of
which are beyond the  control of the  Company,  but not limited to the risk that
Five Star will not achieve the projected levels of  profitability  and revenues,
the risk that the Company's  preparations with respect to the risks presented by
the year 2000  issue will not be  adequate,  and those  risks and  uncertainties
detailed in the Company's  periodic  reports and  registration  statements filed
with the Securities and Exchange Commission.




<PAGE>


                    FIVE STAR PRODUCTS, INC. AND SUBSIDIARIES

                 QUALIFICATION RELATING TO FINANCIAL INFORMATION

                               September 30, 1999


         The financial  information  included herein is unaudited.  In addition,
the  financial  information  does not include  all  disclosures  required  under
generally  accepted  accounting  principles  because  certain  note  information
included  in the  Company's  Annual  Report  has  been  omitted;  however,  such
information  reflects all  adjustments  (consisting  solely of normal  recurring
adjustments)  which are,  in the  opinion  of  management,  necessary  to a fair
statement  of the  results  for the  interim  periods.  The results for the 1999
interim periods are not necessarily indicative of results to be expected for the
entire year.



<PAGE>


                    FIVE STAR PRODUCTS, INC. AND SUBSIDIARIES

                           PART II. OTHER INFORMATION


Item 4.       SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

              (b) At the Annual Meeting of Stockholders held on August 10, 1999,
the following  individuals were elected to serve as directors of the Company for
a one-year term, with each individual nominee receiving the following votes:

         Director                         Votes For              Votes Withheld

         Jerome I. Feldman                10,137,805               93,982,000
         Richard T. Grad                  10,181,701               50,086,000
         Charles Dawson                   10,185,001               46,786,000
         Bruce Sherman                    10,172,163               59,624,000
         Steven Schilit                   10,185,001               46,786,000
         Scott N. Greenberg               10,185,001               46,786,000
         Michael D. Feldman               10,146,113               85,674,000

              (c)  The   proposal  to  amend  the   Company's   Certificate   of
Incorporation,  as amended,  changing the name of the Company from American Drug
Company to Five Star Products,  Inc. received 10,163,998 votes for, 48,081 votes
against, and 19,708 votes withheld.

Item 6.       EXHIBITS AND REPORTS ON FORM 8-K

              a.  Exhibits

                  3(i). Certificate of Amendment of Certificate of Incorporation
of American Drug Company  changing its name to Five Star  Products,  Inc.  filed
with the State of Delaware on August 10, 1999.

                  19. Copy of Notice of Meeting and Proxy  Statement  for Annual
Meeting of Shareholders  held on August 10, 1999,  filed with the Securities and
Exchange Commission pursuant to Section 14 of the Securities and Exchange Act of
1934.


              b.  Reports on Form 8-K

              None


<PAGE>


                    FIVE STAR PRODUCTS, INC. AND SUBSIDIARIES



                               September 30, 1999


                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934, the
registrant  has duly  caused  this  report  to be  signed  in its behalf by the
undersigned thereunto duly authorized.


                                                  FIVE STAR PRODUCTS, INC.



DATE: November 15, 1999                           BY:   Richard T. Grad
                                                        President


DATE: November 15, 1999                           BY:   Cynthia Krugman
                                                        Vice President





<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000922408
<NAME> FIVE STAR PRODUCTS, INC.

<S>                                           <C>
<PERIOD-TYPE>                              9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                              89
<SECURITIES>                                         0
<RECEIVABLES>                                   12,065
<ALLOWANCES>                                       645
<INVENTORY>                                     20,907
<CURRENT-ASSETS>                                33,116
<PP&E>                                           1,202
<DEPRECIATION>                                     306
<TOTAL-ASSETS>                                  34,088
<CURRENT-LIABILITIES>                           28,031
<BONDS>                                           5,00
                                0
                                          0
<COMMON>                                           130
<OTHER-SE>                                         927
<TOTAL-LIABILITY-AND-EQUITY>                    34,088
<SALES>                                         65,527
<TOTAL-REVENUES>                                65,527
<CGS>                                           54,411
<TOTAL-COSTS>                                   63,418
<OTHER-EXPENSES>                                 8,917
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,249
<INCOME-PRETAX>                                    860
<INCOME-TAX>                                       387
<INCOME-CONTINUING>                                474
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       474
<EPS-BASIC>                                        .04
<EPS-DILUTED>                                      .03


</TABLE>

                            CERTIFICATE OF AMENDMENT
                                       OF
                          CERTIFICATE OF INCORPORATION
                                                               * * * * *
         American Drug Company,  a corporation  organized and existing under and
by virtue of the General  Corporation Law of the State of Delaware,  DOES HEREBY
CERTIFY to the Secretary of State of the Sate of Delaware that:

         FIRST:  That the Board of Directors of American  Drug  Company,  by the
unanimous  written consent of its members,  filed with the minutes of the board,
duly adopted  resolutions  setting forth a proposed amendment to the Certificate
of Incorporation of said  corporation,  declaring said amendment to be advisable
and calling a meeting of  stockholders  of said  corporation  for  consideration
thereof. The resolution setting forth the proposed amendment is as follows:

         RESOLVED,  that the Board of Directors hereby declares it advisable and
in the best interests of the Corporation and its stockholders that Article First
of  the  Certificate  of  Incorporation  of  the  Corporation  be  amended  (the
"Amendment") in its entirety to read as follows:

              FIRST.     The name of the Corporation is

                            Five Star Products, Inc.

         SECOND:  That  thereafter,  pursuant  to a  resolution  of its Board of
Directors,  an Annual Meeting of the  Stockholders of said  Corporation was duly
called and held,  upon  notice in  accordance  with  Section  222 of the General
Corporation Law of the State of Delaware.

         THIRD:   The foregoing amendment was duly adopted in accordance with
the provisions of Section 242 of the General Corporation Law of the State of
Delaware.

         IN WITNESS  WHEREOF,  American Drug Company has caused this Certificate
of  Amendment  to be  signed  in its name  and on its  behalf  by its  Corporate
Secretary this 28th day of July, 1999. The undersigned  officer of American Drug
Company acknowledges,  under the penalties for perjury, that this Certificate of
Amendment of the  Certificate  of  Incorporation  is the  corporate  act of said
Corporation and that, to the best of her knowledge,  information and belief, the
matters set forth herein are true in all material respects.

                                        AMERICAN DRUG COMPANY



                                        BY:   ______________________________
                                              Lydia M. DeSantis
                                              Corporate Secretary




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission